Company / Assets per Share
Gilead Sciences Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$47.37
FY2025
5-year range
$47.35 / $54.19
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#23 of 210
Health Care
What the data says
Gilead Sciences's assets per share of $47.37 is higher than 89% of companies in the Health Care sector (FY2025). Assets per Share returned to growth in FY2025 after 3 years of decline, reaching $47.37.
Based on SEC 10-K filings.
47.37 in FY2025 with a 5-year CAGR of -2.6%. Top quartile in the Health Care sector.
Declined from $49.82 to $47.37 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 210This company $47.37 Sector average $353.15
▼
-86.6% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 0.0% year-over-year.
- Ranks #23 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.37 | +0.0% |
| FY2024 | $47.35 | -5.0% |
| FY2023 | $49.82 | -1.1% |
| FY2022 | $50.38 | -7.0% |
| FY2021 | $54.19 | +0.3% |
| FY2020 | $54.03 | +12.4% |
| FY2019 | $48.07 | -1.3% |
| FY2018 | $48.68 | -9.3% |
| FY2017 | $53.65 | +33.9% |
| FY2016 | $40.07 | +16.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026